PitchBook’s 2026 Healthcare Outlook sees a broad rebound across biopharma, medtech, healthtech, and healthcare services driven in large part by AI-powered drug discovery and efficiency gains that could significantly boost clinical success rates and investor returns. The report also highlights rising merger and acquisition activity, selective IPO opportunities, and mounting healthcare policy reforms that together are expected to reshape funding flows and strategic priorities in the healthcare sector next year.
713-782-3777
